Compounds > camptothecin
Page last updated: 2024-08-22

camptothecin and adamantane

camptothecin has been researched along with adamantane in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, YC; Chern, YT; Chi, CW; Lee, JY; Wang, JJ1
Cao, Y; Chen, JT; Liu, Y; Yang, Y; Zhang, YM1
Fan, HX; Li, D; Liu, Y; Sun, HL; Yang, Y; Zhang, YM1
An, G; Chen, H; Lim, WQ; Phua, FSZ; Yang, D; Yang, P; Zhang, Y; Zhao, Y1
Liu, Y; Sheng, X; Wang, J; Zhang, YH; Zhang, YM1

Other Studies

5 other study(ies) available for camptothecin and adamantane

ArticleYear
The antitumor effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl) adamantane (DPA), in combinatory therapy on human colon cancer.
    International journal of oncology, 2006, Volume: 28, Issue:4

    Topics: Adamantane; Animals; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Blotting, Western; Cadherins; Camptothecin; Carcinoembryonic Antigen; Catenins; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Delta Catenin; Dose-Response Relationship, Drug; Drug Synergism; Fibronectins; G1 Phase; HT29 Cells; Humans; Intracellular Signaling Peptides and Proteins; Irinotecan; Male; Mice; Mice, Inbred ICR; Mice, Nude; Phosphoproteins; Resting Phase, Cell Cycle; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2006
A small-sized graphene oxide supramolecular assembly for targeted delivery of camptothecin.
    Chemical communications (Cambridge, England), 2014, Nov-07, Volume: 50, Issue:86

    Topics: Adamantane; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Carriers; Graphite; Humans; Hyaluronic Acid; Mice; NIH 3T3 Cells; Oxides

2014
Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.
    Bioconjugate chemistry, 2016, Dec-21, Volume: 27, Issue:12

    Topics: Adamantane; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Camptothecin; Delayed-Action Preparations; Drug Carriers; Drug Screening Assays, Antitumor; Dynamic Light Scattering; HCT116 Cells; Humans; Hyaluronic Acid; Mice; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Nanoparticles; NIH 3T3 Cells; Solubility

2016
Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy.
    Biomaterials, 2018, Volume: 163

    Topics: Adamantane; Animals; Antineoplastic Agents; Benzoates; Camptothecin; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Drug Carriers; Female; Fluorescent Dyes; Humans; Hyaluronic Acid; Hydrophobic and Hydrophilic Interactions; Indoles; Infrared Rays; Mice; Nanoparticles; Neoplasm Transplantation; Oxidation-Reduction; Phototherapy; Polymers; Prodrugs

2018
Enzyme-responsive fluorescent camptothecin prodrug/polysaccharide supramolecular assembly for targeted cellular imaging and in situ controlled drug release.
    Chemical communications (Cambridge, England), 2020, Jan-23, Volume: 56, Issue:7

    Topics: Adamantane; Animals; Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Drug Carriers; Drug Liberation; Fluorescent Dyes; HCT116 Cells; Humans; Hyaluronic Acid; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Naphthalimides; NIH 3T3 Cells; Prodrugs

2020